Results 71 to 80 of about 13,759 (198)
Massive Pulmonary Hemorrhage As A Complication of Intrapleural Streptokinase Therapy [PDF]
Intrapleural streptokinase therapy (IST) is commonly used to manage pediatric parapneumonic effusion. Although considered safe, rare complications, such as pulmonary hemorrhage, have been reported, particularly in high-dose IST administration in patients
Aliyyah Mohammad Khuzaini +2 more
core +1 more source
streptokinase and staphylokinase
, 1980 학위논문 (석사) - 한국과학기술원 : 생물공학과, 1980.2, [ [vii], 55 p. ]The activation of plasminogen to an active fibrinolytic enzyme, plasmin, by Streptokinase and Staphylokinase was studied using caseinolytic assay method.
민흥식, Min, Heung-Shik
core +1 more source
Ancient Science of Life, 2017 Aims and Objectives: In vitro evaluation and comparison of thrombolytic activity of raw and purified bhallātaka (Semecarpus anacardium Linn.f.) nuts by means of % of clot lysis.
Dattatray D Sarvade +2 more
doaj +1 more source
Guillain-Barré Syndrome after Thrombolysis with Streptokinase [PDF]
, 2010 Guillain-Barre syndrome (GBS) is an eponym for a heterogeneous group of immune-mediated peripheral neuropathies. We describe a case of GBS in a patient who recieved intravenous streptokinase therapy for acute anterior myocardial infarction.
Mehmet Akif Cakar +2 more
core +1 more source
Transient acute renal failure after coronary thrombolysis with streptokinase
Revista Cubana de Medicina Militar, 2021 Introduction: There are currently more than 150 medications related to the appearance of rhabdomyolysis and transient acute renal failure. Streptokinase can be one of them.
Rodolfo Vega Candelario +1 more
doaj
INDIGENOUS RECOMBINANT STREPTOKINASE VS NATURAL STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION PATIENTS: PHASE III MULTICENTRIC RANDOMIZED DOUBLE BLIND TRIAL [PDF]
, 2005 Background : Streptokinase is the most widely used thrombolytic agent and can now be made using recombinant DNA technology. The present trial was initiated to assess an indigenous recombinant streptokinase (Shankinase, r-SK).
S. K. Diwedi +10 more
core +1 more source
TITANIUM NANOPARTICLES CONJUGATED WITH STREPTOKINASE AS A MODIFIED THROMBOLYTIC AGENT [PDF]
, 2020 Objective: Blood clots are the main cause of death worldwide by stroke and myocardial infarction. Streptokinase a thrombolytic agent that is used in the treatment of circulatory disorders.
ABED, HAYDER H. +2 more
core +1 more source
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2009 BACKGROUND AND OBJECTIVE: Streptokinase (SK) is a microbial plasminogen-activator that is used in the treatments, especially at Acute ischemic stroke, declotting of dialysis shunts and inflammatory antibiotic-resistant prostatitis.
MR Nejadmoghaddam, +2 more
doaj
UK controlled trial of intrapleural streptokinase for pleural infection [PDF]
, 2005 Background: Intrapleural fibrinolytic agents are used in the drainage of infected pleural-fluid collections. This use is based on small trials that did not have the statistical power to evaluate accurately important clinical outcomes, including safety ...
Nunn, A.J. +30 more
core +1 more source
Thrombus Localization By Using Streptokinase Containing Vesicular Systems
, 2006 Our research focused on the preparation of vesicular drug delivery systems, such as liposomes, noisomes, and sphingosomes, for achieving slow release of entrapped proteins in the circulation to increase half-life, to mask immunogenic properties, and to ...
Oezer, A. Yekta +4 more
core +1 more source